Nifty

:

23960.60

Sensex

:

77301.40

149.75 (0.63%)
383.55 (0.50%)

Login

Nifty
Sensex

:
:

23960.60
77301.40

149.75 (0.63%)
383.55 (0.50%)

Marksans Pharma Ltd.

Pharmaceuticals & Drugs - Global

Rating :

71/99

BSE: 524404 | NSE: MARKSANS

Watchlist

NSE BSE

301.65

04-Nov-2026

Open
High
Low
Previous Close

316.9
327
296.6
315.30

Volume
Traded Value (lacs)
52 Week High
52 Week Low

5961751
1854067708.4
350.95
155

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

13,648.72
24.38
1

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

12,616.49
0.30%
4.29

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

14.42
14.63
10.66

EBITDA CAGR (%)

10 Years
5 Years
3 Years

33.70
18.34
5.55

PAT CAGR (%)

10 Years
5 Years
3 Years

47.07
17.76
10.03

P:E (Median)

8 Years
5 Years
3 Years

15.57
22.44
25.86

P:BV (Average)

8 Years
5 Years
3 Years

2.91
3.28
4.08

EV:EBITDA (Average)

8 Years
5 Years
3 Years

10.72
12.43
15.82

Earnings Forecasts:

(Updated: 31-10-2026)

Description 2026 2027 2028 2029
Adj EPS 9.22 12.57 15.28 18.11
P/E Ratio 32.72 24.00 19.74 16.66
Revenue 2950.94 3568.75 4108.1 4759.8
EBITDA 600.78 785.4 938.2 1096.6
Net Income 417.9 569.75 692.75 820.95
ROA 11.77 - - -
P/B Ratio 4.52 3.85 3.28 2.75
ROE 15.22 17.83 17.75 -
FCFF 351.06 553.3 549.7 -
FCFF Yield 2.76 4.35 4.32 -
Net Debt -646.27 -1421.4 -1833.8 -2306.3
BVPS 66.71 78.36 91.9 109.67

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Sep 26 Sep 25 Var% Jun 26 Jun 25 Var% Mar 26 Mar 25 Var% Dec 25 Dec 24 Var%
Net Sales 313.80 320.44 -2.07% 321.19 319.73 0.46% 361.57 299.36 20.78% 339.73 311.87 8.93%
Expenses 261.45 248.37 5.27% 239.08 249.68 -4.25% 255.58 247.60 3.22% 264.28 260.19 1.57%
EBITDA 52.36 72.07 -27.35% 82.10 70.05 17.20% 105.99 51.76 104.77% 75.44 51.68 45.98%
EBIDTM 16.68% 22.49% 25.56% 21.91% 29.31% 17.29% 22.21% 16.57%
Other Income 57.24 58.19 -1.63% 17.47 2.01 769.15% 27.48 6.64 313.86% 15.86 30.77 -48.46%
Interest 0.34 0.32 6.25% 0.34 0.30 13.33% 0.35 0.31 12.90% 0.36 0.30 20.00%
Depreciation 9.05 8.46 6.97% 8.78 8.19 7.20% 8.76 8.18 7.09% 8.83 7.42 19.00%
PBT 100.21 121.49 -17.52% 90.46 63.57 42.30% 124.36 49.90 149.22% 82.12 74.72 9.90%
Tax 14.67 21.69 -32.37% 21.42 15.52 38.02% 32.44 12.31 163.53% 21.20 19.26 10.07%
PAT 85.54 99.81 -14.30% 69.04 48.06 43.65% 91.92 37.59 144.53% 60.91 55.46 9.83%
PATM 27.26% 31.15% 21.49% 15.03% 25.42% 12.56% 17.93% 17.78%
EPS 1.89 2.20 -14.09% 1.52 1.06 43.40% 2.03 0.83 144.58% 1.34 1.22 9.84%

Description Sep 26 Sep 25 Var% Jun 26 Jun 25 Var% Mar 26 Mar 25 Var% Dec 25 Dec 24 Var%
Net Sales 940.17 720.41 30.50% 840.80 619.99 35.62% 856.11 708.46 20.84% 754.43 681.85 10.64%
Expenses 725.88 575.92 26.04% 627.76 519.87 20.75% 660.69 581.52 13.61% 593.69 551.35 7.68%
EBITDA 214.29 144.49 48.31% 213.03 100.12 112.77% 195.42 126.93 53.96% 160.74 130.50 23.17%
EBIDTM 22.79% 20.06% 25.34% 16.15% 22.83% 17.92% 21.31% 19.14%
Other Income 18.15 21.57 -15.86% 25.40 5.64 350.35% 35.17 15.34 129.27% 20.14 36.11 -44.23%
Interest 6.83 5.81 17.56% 7.00 6.06 15.51% 6.31 3.44 83.43% 5.94 2.67 122.47%
Depreciation 32.11 26.92 19.28% 24.86 23.10 7.62% 24.29 22.74 6.82% 24.33 20.69 17.59%
PBT 193.50 133.33 45.13% 206.57 76.60 169.67% 200.00 116.09 72.28% 150.62 143.26 5.14%
Tax 49.98 34.20 46.14% 47.16 18.40 156.30% 50.97 25.37 100.91% 36.93 38.19 -3.30%
PAT 143.53 99.14 44.78% 159.41 58.20 173.90% 149.03 90.73 64.26% 113.69 105.07 8.20%
PATM 15.27% 13.76% 18.96% 9.39% 17.41% 12.81% 15.07% 15.41%
EPS 3.12 2.17 43.78% 3.47 1.29 168.99% 3.27 2.00 63.50% 2.50 2.31 8.23%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Net Sales 1,336.29 1,341.48 1,174.37 853.27 655.20 658.29 599.55 433.42 424.16 294.66 215.84 Net Sales Growth 6.78% 14.23% 37.63% 30.23% -0.47% 9.80% 38.33% 2.18% 43.95% 36.52% Cost Of Goods Sold 672.43 678.79 639.94 478.93 394.44 377.59 337.91 245.41 236.34 169.35 112.37 Gross Profit 663.86 662.69 534.44 374.34 260.75 280.70 261.63 188.00 187.82 125.31 103.47 GP Margin 49.68% 49.40% 45.51% 43.87% 39.80% 42.64% 43.64% 43.38% 44.28% 42.53% 47.94% Total Expenditure 1,020.39 1,017.91 966.28 713.34 582.23 544.57 485.84 361.93 360.83 265.52 202.15 Power & Fuel Cost - 32.95 30.73 26.04 14.24 11.49 10.90 8.95 8.44 7.26 7.21 % Of Sales - 2.46% 2.62% 3.05% 2.17% 1.75% 1.82% 2.06% 1.99% 2.46% 3.34% Employee Cost - 121.98 101.68 77.19 56.09 60.46 54.64 48.51 46.33 45.86 39.77 % Of Sales - 9.09% 8.66% 9.05% 8.56% 9.18% 9.11% 11.19% 10.92% 15.56% 18.43% Manufacturing Exp. - 65.94 64.62 46.09 26.22 5.25 12.29 8.68 12.69 11.52 11.99 % Of Sales - 4.92% 5.50% 5.40% 4.00% 0.80% 2.05% 2.00% 2.99% 3.91% 5.56% General & Admin Exp. - 31.63 36.24 27.40 21.36 16.58 14.79 16.19 22.68 10.95 10.61 % Of Sales - 2.36% 3.09% 3.21% 3.26% 2.52% 2.47% 3.74% 5.35% 3.72% 4.92% Selling & Distn. Exp. - 65.08 76.75 45.79 53.97 59.37 52.67 33.84 34.30 20.58 20.20 % Of Sales - 4.85% 6.54% 5.37% 8.24% 9.02% 8.78% 7.81% 8.09% 6.98% 9.36% Miscellaneous Exp. - 21.55 16.32 11.88 15.89 13.84 2.64 0.34 0.04 0.00 20.20 % Of Sales - 1.61% 1.39% 1.39% 2.43% 2.10% 0.44% 0.08% 0.01% 0% 0% EBITDA 315.89 323.57 208.09 139.93 72.97 113.72 113.71 71.49 63.33 29.14 13.69 EBITDA Margin 23.64% 24.12% 17.72% 16.40% 11.14% 17.28% 18.97% 16.49% 14.93% 9.89% 6.34% Other Income 118.05 103.53 65.79 62.07 79.41 42.25 31.16 0.17 7.93 7.43 17.75 Interest 1.39 1.33 1.17 0.99 3.61 3.80 5.34 7.29 6.56 7.67 4.49 Depreciation 35.42 34.23 29.45 29.13 16.74 17.66 15.19 11.64 8.69 12.25 15.00 PBT 397.15 391.54 243.26 171.89 132.03 134.51 124.33 52.73 56.01 16.65 11.95 Tax 89.73 90.84 54.99 38.13 29.17 30.52 25.95 14.82 12.39 4.23 0.40 Tax Rate 22.59% 23.20% 22.61% 22.18% 22.09% 22.69% 20.87% 28.11% 22.12% 25.41% 3.35% PAT 307.41 300.70 188.27 133.76 102.87 103.99 98.38 37.90 43.62 12.43 11.55 PAT before Minority Interest 307.41 300.70 188.27 133.76 102.87 103.99 98.38 37.90 43.62 12.43 11.55 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 23.00% 22.42% 16.03% 15.68% 15.70% 15.80% 16.41% 8.74% 10.28% 4.22% 5.35% PAT Growth 27.60% 59.72% 40.75% 30.03% -1.08% 5.70% 159.58% -13.11% 250.93% 7.62% EPS 6.78 6.64 4.15 2.95 2.27 2.29 2.17 0.84 0.96 0.27 0.25

Description TTM Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Net Sales 3,391.51 2,950.94 2,622.84 2,177.41 1,852.14 1,490.84 1,376.18 1,134.21 1,000.07 912.69 767.16 Net Sales Growth 24.20% 12.51% 20.46% 17.56% 24.23% 8.33% 21.33% 13.41% 9.57% 18.97% Cost Of Goods Sold 1,440.42 1,277.28 1,143.74 1,038.12 921.36 716.81 595.05 567.83 498.01 523.13 458.74 Gross Profit 1,951.09 1,673.66 1,479.10 1,139.29 930.78 774.02 781.13 566.38 502.07 389.57 308.42 GP Margin 57.53% 56.72% 56.39% 52.32% 50.25% 51.92% 56.76% 49.94% 50.20% 42.68% 40.20% Total Expenditure 2,608.02 2,350.16 2,090.16 1,718.83 1,512.82 1,231.96 1,036.58 941.96 867.93 834.31 734.24 Power & Fuel Cost - 54.08 40.08 36.94 24.50 18.59 16.42 14.38 14.34 11.83 13.27 % Of Sales - 1.83% 1.53% 1.70% 1.32% 1.25% 1.19% 1.27% 1.43% 1.30% 1.73% Employee Cost - 420.93 350.30 293.64 239.37 220.30 197.32 168.42 159.07 147.75 149.70 % Of Sales - 14.26% 13.36% 13.49% 12.92% 14.78% 14.34% 14.85% 15.91% 16.19% 19.51% Manufacturing Exp. - 155.88 140.08 94.76 96.47 12.73 49.76 64.44 77.14 59.90 47.34 % Of Sales - 5.28% 5.34% 4.35% 5.21% 0.85% 3.62% 5.68% 7.71% 6.56% 6.17% General & Admin Exp. - 109.99 117.60 93.90 52.79 37.74 50.67 45.52 51.03 42.51 37.52 % Of Sales - 3.73% 4.48% 4.31% 2.85% 2.53% 3.68% 4.01% 5.10% 4.66% 4.89% Selling & Distn. Exp. - 260.26 256.64 127.31 133.19 119.05 111.25 81.03 68.36 49.14 27.66 % Of Sales - 8.82% 9.78% 5.85% 7.19% 7.99% 8.08% 7.14% 6.84% 5.38% 3.61% Miscellaneous Exp. - 71.74 41.72 34.16 45.14 106.73 16.10 0.34 0.00 0.05 27.66 % Of Sales - 2.43% 1.59% 1.57% 2.44% 7.16% 1.17% 0.03% 0% 0.01% 0% EBITDA 783.48 600.78 532.68 458.58 339.32 258.88 339.60 192.25 132.14 78.38 32.92 EBITDA Margin 23.10% 20.36% 20.31% 21.06% 18.32% 17.36% 24.68% 16.95% 13.21% 8.59% 4.29% Other Income 98.86 82.53 66.33 50.42 59.31 41.85 6.69 0.33 4.63 8.47 18.86 Interest 26.08 24.13 11.66 11.20 9.13 8.45 7.99 8.75 9.66 10.22 6.79 Depreciation 105.59 98.63 83.39 74.27 51.85 44.78 36.15 26.66 22.80 26.84 30.09 PBT 750.69 560.55 503.97 423.53 337.65 247.51 302.16 157.17 104.31 49.80 14.90 Tax 185.04 140.49 121.35 108.63 72.33 60.70 63.63 36.42 23.87 14.00 3.56 Tax Rate 24.65% 25.06% 24.08% 25.65% 21.42% 24.52% 21.06% 23.17% 22.88% 28.11% 23.89% PAT 565.66 417.90 380.58 313.69 266.31 184.56 235.94 117.02 76.46 32.94 8.83 PAT before Minority Interest 559.82 420.06 382.62 314.89 265.32 186.81 238.54 120.75 80.44 35.80 11.33 Minority Interest -5.84 -2.16 -2.04 -1.20 0.99 -2.25 -2.60 -3.73 -3.98 -2.86 -2.50 PAT Margin 16.68% 14.16% 14.51% 14.41% 14.38% 12.38% 17.14% 10.32% 7.65% 3.61% 1.15% PAT Growth 60.18% 9.81% 21.32% 17.79% 44.29% -21.78% 101.62% 53.05% 132.12% 273.05% EPS 12.48 9.22 8.40 6.92 5.88 4.07 5.21 2.58 1.69 0.73 0.19

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Shareholder's Funds 1,652.31 1,383.49 1,222.70 1,111.32 784.67 599.72 505.63 470.57 428.97 418.88 Share Capital 45.32 45.32 45.32 45.32 40.93 40.93 40.93 40.93 40.93 40.93 Total Reserves 1,603.66 1,338.17 1,177.39 1,066.01 650.64 558.79 464.69 429.64 388.04 377.95 Non-Current Liabilities 31.47 26.18 20.89 17.00 14.41 23.93 24.79 18.39 17.09 17.30 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 5.69 5.77 4.47 3.18 1.86 2.11 1.47 1.36 1.08 0.96 Current Liabilities 371.86 386.49 304.73 240.91 190.39 137.26 79.73 135.92 113.53 109.59 Trade Payables 180.81 203.53 159.72 111.58 74.45 64.16 56.65 37.23 33.68 20.60 Other Current Liabilities 105.61 130.13 105.84 97.65 78.95 42.70 10.92 7.34 8.79 0.71 Short Term Borrowings 0.00 0.00 0.00 0.00 5.00 0.00 0.00 77.33 66.31 73.23 Short Term Provisions 85.44 52.83 39.16 31.68 31.99 30.40 12.15 14.03 4.75 15.04 Total Liabilities 2,055.64 1,796.16 1,548.32 1,369.23 989.47 760.91 610.15 624.88 559.59 545.77 Net Block 397.96 383.37 271.57 143.94 135.51 129.09 115.18 102.61 87.89 93.92 Gross Block 603.11 555.16 414.10 318.89 301.34 277.25 248.77 224.90 201.83 195.61 Accumulated Depreciation 205.15 171.79 142.52 174.95 165.83 148.16 133.59 122.28 113.94 101.69 Non Current Assets 684.95 673.08 568.33 431.10 375.75 369.32 355.73 339.98 324.78 329.16 Capital Work in Progress 0.00 0.00 0.00 3.90 0.00 0.00 0.00 0.00 0.00 0.36 Non Current Investment 267.21 265.75 265.75 265.75 236.07 236.07 236.07 236.07 236.07 234.29 Long Term Loans & Adv. 19.77 23.79 30.84 17.50 4.16 4.16 4.47 1.29 0.82 0.59 Other Non Current Assets 0.01 0.17 0.17 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 1,370.68 1,123.08 979.99 938.13 613.73 391.60 254.41 284.90 234.81 216.61 Current Investments 0.00 0.74 26.99 0.54 0.44 0.26 0.00 0.00 0.00 0.00 Inventories 189.13 205.21 190.85 130.95 103.67 93.69 74.60 70.36 42.29 29.24 Sundry Debtors 623.46 549.58 370.17 305.49 246.78 168.93 161.87 177.83 168.87 154.80 Cash & Bank 446.76 268.69 312.23 440.26 224.05 105.61 3.35 1.80 0.71 2.56 Other Current Assets 111.33 8.96 11.74 7.17 38.79 23.11 14.58 34.90 22.93 30.01 Short Term Loans & Adv. 99.80 89.89 68.00 53.71 26.73 21.20 13.76 27.43 16.85 29.92 Net Current Assets 998.83 736.59 675.27 697.22 423.34 254.34 174.68 148.98 121.28 107.02 Total Assets 2,055.63 1,796.16 1,548.32 1,369.23 989.48 760.92 610.14 624.88 559.59 545.77

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Shareholder's Funds 3,023.16 2,466.91 2,065.05 1,745.16 1,202.27 886.50 636.01 542.48 470.86 433.43 Share Capital 45.32 45.32 45.32 45.32 40.93 40.93 40.93 40.93 40.93 40.93 Total Reserves 2,974.50 2,421.60 2,019.74 1,699.85 1,068.24 845.56 595.08 501.55 429.93 392.50 Non-Current Liabilities 268.17 272.91 205.20 84.33 57.05 23.70 24.15 17.14 15.64 16.07 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 5.92 5.92 4.56 3.25 1.86 2.11 1.47 1.36 1.08 0.96 Current Liabilities 527.09 477.34 389.85 340.99 380.08 298.97 228.75 232.62 234.68 296.06 Trade Payables 336.91 305.70 268.28 230.60 200.08 168.66 110.33 106.07 77.83 161.78 Other Current Liabilities 118.69 117.17 70.62 42.20 96.80 79.69 58.86 20.90 10.08 0.71 Short Term Borrowings 29.59 23.09 29.09 41.59 41.29 18.74 18.84 99.91 117.41 109.71 Short Term Provisions 41.90 31.39 21.86 26.60 41.92 31.88 40.72 5.74 29.36 23.85 Total Liabilities 3,847.94 3,239.63 2,680.95 2,190.39 1,660.10 1,228.03 902.02 802.46 730.73 751.81 Net Block 1,044.11 981.96 775.94 486.31 428.31 309.36 302.72 269.73 279.38 266.98 Gross Block 1,605.35 1,413.02 1,134.80 828.26 726.26 551.92 565.39 506.26 495.35 456.49 Accumulated Depreciation 561.24 431.06 358.87 341.95 297.96 242.56 262.67 236.54 215.97 189.52 Non Current Assets 1,125.20 1,035.51 818.46 515.09 435.04 325.20 308.45 271.02 280.19 267.92 Capital Work in Progress 58.58 27.11 9.42 9.87 2.57 11.68 0.00 0.00 0.00 0.36 Non Current Investment 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 22.50 26.27 32.94 18.91 4.16 4.16 5.73 1.29 0.82 0.59 Other Non Current Assets 0.01 0.17 0.17 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 2,722.74 2,204.12 1,862.49 1,675.30 1,225.07 902.82 593.59 531.44 450.54 483.88 Current Investments 0.00 0.74 26.99 0.54 0.44 0.26 0.00 0.00 0.00 0.00 Inventories 972.28 845.52 617.94 484.74 424.44 404.32 241.84 293.25 218.12 190.09 Sundry Debtors 644.57 540.04 453.18 416.85 394.78 271.95 243.35 176.60 176.91 247.58 Cash & Bank 989.65 704.21 673.58 714.96 349.26 212.18 93.73 33.54 39.88 25.16 Other Current Assets 116.25 32.41 30.98 22.74 56.15 14.11 14.66 28.06 15.63 21.05 Short Term Loans & Adv. 76.05 81.20 59.82 35.48 31.79 0.98 3.40 0.00 0.00 20.96 Net Current Assets 2,195.65 1,726.78 1,472.64 1,334.31 844.98 603.85 364.83 298.82 215.86 187.82 Total Assets 3,847.94 3,239.63 2,680.95 2,190.39 1,660.11 1,228.02 902.04 802.46 730.73 751.80

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Cash From Operating Activity 211.09 31.02 34.05 51.73 55.97 106.92 107.58 19.81 15.63 -13.62 PBT 391.54 243.26 171.89 132.03 134.51 124.33 52.73 56.01 16.65 11.95 Adjustment -24.66 -7.59 -16.40 10.91 -7.93 -8.82 19.17 11.57 20.00 12.50 Changes in Working Capital -82.79 -158.11 -82.68 -59.60 -38.77 11.62 46.17 -34.91 -16.33 -22.39 Cash after chg. in Working capital 284.09 77.56 72.82 83.34 87.80 127.13 118.06 32.67 20.32 2.06 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -73.01 -46.54 -38.76 -31.62 -31.83 -20.21 -10.49 -12.86 -4.68 -15.69 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -140.29 17.24 -114.22 -194.62 -128.06 8.87 -24.15 -20.20 -7.55 -7.69 Net Fixed Assets -47.95 -141.06 -91.31 -21.45 -24.09 -28.48 -23.87 -23.07 -5.86 -11.49 Net Investments -0.72 26.25 -26.45 -29.78 -0.18 -0.26 0.00 0.00 -1.78 -2.85 Others -91.62 132.05 3.54 -143.39 -103.79 37.61 -0.28 2.87 0.09 6.65 Cash from Financing Activity -39.23 -29.92 -26.21 210.02 70.86 -13.53 -81.87 0.96 -9.98 20.74 Net Cash Inflow / Outflow 31.56 18.34 -106.38 67.12 -1.23 102.26 1.55 0.56 -1.90 -0.57 Opening Cash & Equivalents 60.27 41.93 148.31 81.19 82.42 3.35 1.80 0.55 2.45 3.13 Closing Cash & Equivalent 91.25 60.27 41.93 148.31 81.19 105.61 3.35 1.12 0.55 2.56

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Cash From Operating Activity 458.13 206.66 230.41 237.41 99.26 178.59 233.33 27.40 50.09 14.06 PBT 560.55 503.97 423.53 337.65 247.51 302.16 157.17 104.31 49.80 14.90 Adjustment 99.68 69.37 55.42 74.24 35.31 56.57 42.04 31.88 43.99 26.58 Changes in Working Capital -62.46 -240.77 -126.19 -111.47 -110.70 -131.61 59.12 -81.79 -36.23 -6.04 Cash after chg. in Working capital 597.78 332.56 352.76 300.43 172.12 227.12 258.33 54.40 57.56 35.44 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -139.65 -125.90 -122.35 -63.01 -72.86 -48.53 -25.00 -27.00 -7.46 -21.37 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -248.27 -49.01 -140.84 -259.21 -84.39 -44.85 -59.58 -13.48 -38.81 -20.73 Net Fixed Assets -47.95 -141.06 -91.31 -21.45 -24.09 -28.48 -23.87 -23.07 -5.86 -11.49 Net Investments -0.72 26.25 -26.45 -29.78 -0.18 -0.26 0.00 0.00 -1.78 -2.85 Others -199.60 65.80 -23.08 -207.98 -60.12 -16.11 -35.71 9.59 -31.17 -6.39 Cash from Financing Activity -70.93 -65.15 -68.73 197.83 79.51 -15.29 -113.55 -20.78 3.38 -3.47 Net Cash Inflow / Outflow 138.93 92.51 20.84 176.03 94.38 118.46 60.19 -6.86 14.67 -10.14 Opening Cash & Equivalents 495.79 403.28 382.44 206.41 112.03 93.73 33.54 39.72 25.05 35.30 Closing Cash & Equivalent 634.14 495.79 403.28 382.44 206.41 212.18 93.73 32.85 39.72 25.16

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Book Value (Rs.) 36.39 30.53 26.98 24.52 16.90 14.65 12.35 11.50 10.48 10.23 ROA 15.61% 11.26% 9.17% 8.72% 11.88% 14.35% 6.15% 7.40% 2.25% 2.14% ROE 19.83% 14.45% 11.46% 11.41% 16.11% 17.80% 7.77% 9.70% 2.93% 2.79% ROCE 25.88% 18.76% 14.81% 14.27% 19.91% 23.46% 11.39% 11.99% 4.92% 3.44% Fixed Asset Turnover 2.38 2.43 2.33 2.24 2.30 2.30 1.83 1.99 1.48 1.14 Receivable days 155.47 142.42 144.13 144.90 114.03 99.91 143.04 149.17 200.47 243.69 Inventory Days 52.26 61.33 68.65 61.56 54.14 50.83 61.04 48.47 44.31 61.71 Payable days 103.34 103.59 103.38 86.07 66.99 65.25 47.33 37.28 36.94 45.72 Cash Conversion Cycle 104.40 100.16 109.41 120.38 101.18 85.49 156.75 160.37 207.84 259.68 Total Debt/Equity 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.17 0.16 0.17 Interest Cover 296.06 208.21 174.98 37.54 36.44 24.26 8.23 9.54 3.17 3.66

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Book Value (Rs.) 66.64 54.44 45.57 38.51 27.10 21.66 15.54 13.25 11.50 10.59 ROA 11.85% 12.93% 12.93% 13.78% 12.94% 22.40% 14.17% 10.49% 4.83% 1.54% ROE 15.31% 16.89% 16.53% 18.59% 18.72% 31.33% 20.49% 15.88% 7.92% 2.59% ROCE 21.10% 22.50% 22.40% 22.89% 23.82% 39.76% 25.57% 18.51% 10.60% 3.99% Fixed Asset Turnover 2.01 2.16 2.33 2.62 2.42 2.49 2.12 2.00 1.92 1.73 Receivable days 71.16 65.99 69.35 72.63 78.56 67.57 67.57 64.51 84.88 110.59 Inventory Days 109.20 97.24 87.89 81.36 97.65 84.73 86.10 93.32 81.63 85.14 Payable days 91.82 91.59 87.70 85.31 93.88 85.57 45.09 38.48 55.10 65.56 Cash Conversion Cycle 88.55 71.65 69.54 68.67 82.33 66.73 108.58 119.35 111.40 130.17 Total Debt/Equity 0.01 0.01 0.01 0.02 0.04 0.02 0.03 0.18 0.25 0.25 Interest Cover 24.24 44.22 38.80 37.99 30.31 38.84 18.97 11.80 5.87 3.20

Top Investors:

orbimed asia iv mauritius fvci limited

uti-healthcare fund

investor education and protection fund (iepf)

Annual Reports:

News Update:

Marksans Pharma - Quarterly Results
13th Aug 2026, 00:00 AM

Read More
Marksans Pharma reports near three-fold jump in Q1 consolidated net profit
12th Aug 2026, 14:28 PM

The total consolidated income of the company has increased by 38.45% at Rs 866.20 crore for Q1FY27
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback